COMMUNIQUÉS West-GlobeNewswire

Sanofi : Assemblée Générale Annuelle du 30 avril 2019
30/04/2019
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Assemblée Générale Annuelle du 30 avril 2019 Approbation des comptes sociaux et des comptes consolidés de l'exercice 2019 Dividende de 3,07 euros par [...]
Homology Medicines Presents Data Demonstrating Suite of Novel AAV Vectors Targeted Key Cell Types for Inherited Retinal Diseases
30/04/2019
Presentation Highlights Targeted Biodistribution in Multiple Models following Different Routes of Administration BEDFORD, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic [...]
Kiadis Pharma announces annual results for the year ended December 31, 2018
30/04/2019
Amsterdam, The Netherlands, 30 April 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a clinical-stage biopharmaceutical company, today announces its audited 2018 [...]
Néovacs : mise à disposition du rapport financier annuel 2018 et du rapport sur le gouvernement d'entreprise
30/04/2019
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2018 ET DU RAPPORT SUR LE GOUVERNEMENT D'ENTREPRISE Paris et Boston, le 30 avril 2019 - 17h45 CEST – [...]
Allscripts Sunrise™ goes live in Gippsland
30/04/2019
First in Australia to incorporate Microsoft’s Azure cloud platform CHICAGO, April 30, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) has expanded its footprint in Australia with a successful go-live at Latrobe [...]
Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2019
30/04/2019
Bagsværd, Denmark, 30 April 2019 - In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share capital in Novo [...]
EndoPredict® Predicts the Chemotherapy Benefit in Women with Early ER-positive, HER2-negative Breast Cancer
30/04/2019
New Study Finds Many Women May Receive Unnecessary Chemotherapy Treatment SALT LAKE CITY, April 30, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today [...]
JSC Olainfarm ESG Report for the Year 2018.
30/04/2019
JSC Olainfarm hereby publishes the ESG Report for the Year 2018. Additional information: Dana Hasana Head of PR dana.hasana@olainfarm.com Ph. +371 26355895 Attachment Olainfarm_ESG_Zinojums_ENG_2019
Axiom Real-Time Metrics Exhibiting at Clinical Operations in Oncology Trials West Coast 2019
30/04/2019
TORONTO, April 30, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at Clinical Operations in Oncology Trials West on April 30 th and May 1 st [...]
Cambrex to Announce First Quarter 2019 Financial Results on May 2, 2019
30/04/2019
EAST RUTHERFORD, N.J., April 30, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
JSC Olainfarm Consolidated and Parent Company's Annual Report for Year 2018
30/04/2019
Olainfarm’s revenues continue to increase; EBITDA margin improves Audited consolidated revenues of JSC Olainfarm for 2018 exceeded 124 million euros. This represents an increase by 2% compared to sales of 2017 and is [...]
PSIQ ANNOUNCES RESELLER AGREEMENT WITH CANNARA BIOTECH SUBSIDIARY SHOPCBD.COM TO MARKET AND SELL ELITES CBD PRODUCT LINE WITHIN THE UNITED STATES
30/04/2019
SUNRISE, Fla., April 30, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), has entered into a Reseller [...]
Mustang Bio Announces Pricing of Public Offering of Common Stock
30/04/2019
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Visual Healthcare Corp. (OTC: VSHC) Announces Share Exchange Agreement and Planned Retirement of 230 Million Shares of Common Stock
30/04/2019
Transaction to Result in 43% Reduction of Outstanding Common Shares Houston, TX, April 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Visual Healthcare Corp. (OTC PINK: VSHC) announces today that a share exchange [...]
BioCorRx to Present at the Planet MicroCap Showcase 2019 on May 1st in Las Vegas
30/04/2019
ANAHEIM, CA, April 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and related [...]
Driven Deliveries Inc. Announces Letter of Intent to Acquire Ganjarunner Inc., Adding Material Revenue Stream to Company
30/04/2019
Deal will Significantly Expand Driven’s Delivery platform throughout $5.1 billion California market SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (DRVD), the world’s first and only publicly [...]
Meridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Provides Fiscal 2019 Guidance for Pending Acquisition
30/04/2019
CINCINNATI, April 30, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter and first six months ended March 31, 2019. Second Quarter 2019 Highlights [...]
Meridian Bioscience Announces Agreement to Acquire Business of GenePOC; Adds State-of-the-Art Molecular Diagnostics Platform
30/04/2019
CINCINNATI, April 30, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced it has entered into a definitive [...]
Mapi Pharma to Present Phase II Extension Results of Glatiramer Acetate Depot (GA Depot) at the 2019 AAN Annual Meeting in Philadelphia on May 7 2019
30/04/2019
81.8% Patients on GA Depot Demonstrated No Evidence of Disease Activity (NEDA) at 2 years NESS ZIONA, Israel, April 30, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development [...]

Pages